Researchers are developing new strategies to drug the undruggable in cancer, including targeting intracellular KRAS with ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets ...

A panelist highlights promising early-phase trial data on trispecific antibodies targeting multiple myeloma antigens and CD3, emphasizing their high response rates, manageable safety profiles, and ...

On June 23, the company announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), which is a long-acting, peptide-antibody conjugate ...

New Monthly GLP-1 Could Be as Good as Ozempic, Mounjaro for Weight Loss MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight.

Expertise: Peptides, Antibodies, Immunogenetics, Immunology, Immunoinformatics Xiaolei Huang Fujian Agriculture and Forestry University, China ...

What sets this new medication apart, though, is that MariTide also contains a “peptide-antibody conjugate molecule,” which extends the drug’s effects.